Status:

COMPLETED

A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets

Lead Sponsor:

Amgen

Conditions:

Healthy Participants

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

Brief Summary

The primary objective of the study is to compare the pharmacokinetics (PK) of sotorasib administered orally as 1 tablet under fasted conditions to sotorasib administered orally as 2 tablets under fast...

Eligibility Criteria

Inclusion

  • Healthy male participants or female participants, between 18 and 60 years of age (inclusive), at the time of Screening.
  • Body mass index, between 18 and 30 kg/m\^2 (inclusive), at the time of Screening.
  • Females of nonchildbearing potential.

Exclusion

  • Inability to swallow oral medication or history of malabsorption syndrome.
  • History of hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance, unless approved by the Investigator (or designee) and in consultation with the Sponsor.
  • Poor peripheral venous access.
  • History or evidence, at Screening or Check in, of clinically significant disorder, condition, or disease, including history of myolysis, not otherwise excluded that, in the opinion of the Investigator (or designee), would pose a risk to participants safety or interfere with the study evaluation, procedures, or completion.

Key Trial Info

Start Date :

March 21 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 17 2022

Estimated Enrollment :

146 Patients enrolled

Trial Details

Trial ID

NCT05327491

Start Date

March 21 2022

End Date

July 17 2022

Last Update

December 14 2023

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Labcorp Clinical Research Unit - Daytona Beach

Daytona Beach, Florida, United States, 32117-5116

2

Miami Research Associates LLC - Main Campus / Late Phase

South Miami, Florida, United States, 33143-5026

3

Labcorp Clinical Research Unit - Dallas

Dallas, Texas, United States, 75247-4989

4

Labcorp Clinical Research Unit - Madison

Madison, Wisconsin, United States, 53704-2526